DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Anderson MA, Tam C, Lew TE, Juneja S, Juneja M, Westerman D. et al.
Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax.
Blood 2017;
129: 3362-70
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.